CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced the availability of a new video featuring Marc D. Beer, Chief Executive Officer of Aegerion, discussing business strategy and objectives related to the company’s lead product candidate, lomitapide. To view the video, please visit: http://ir.aegerion.com. The video may also be accessed here:
